rare diseases
The fight against rare diseases has been slow due to several factors relating to regulations, something Representatives Gus Bilirakis (R-FL) and Doris Matsui (D-CA) seek to amend in recent bipartisan legislation easing the regulatory process between the Food and Drug Administration (FDA) and rare disease specialists so that treatments can be developed more efficiently. As […]